版本:
中国

BRIEF-Biolinerx announces initiation of Phase 2A trial of BL-8040 in combination with Keytruda

Sept 20 BioLine RX Ltd

* Study will be conducted in us, israel and additional territories

* Biolinerx announces initiation of phase 2A trial Of BL-8040 in combination with Keytruda (pembrolizumab) for treatment of pancreatic cancer Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐